RHOA and melanoma: In this work, we demonstrate that a combined treatment approach consisting of suppressed p190RhoGAP expression (leading to constantly increased activity of RhoA) into tumours and inactivation of p110δ PI3K in macrophages blocks melanoma and SCC progression.